Documents

FAQ - Price reduction of the dolutegravir-based antiretroviral therapy regimen

09 February 2018

Price reduction of the dolutegravir-based antiretroviral therapy regimen - Frequently asked questions

Download PDF
Email this link to me

Related

Peru approves groundbreaking law to extend health coverage for migrants with HIV and TB

21 October 2024

Can this innovation change the way people think about HIV?

16 October 2024

United Nations General Assembly debate highlights the need for urgent action to ensure that progress in the HIV response is accelerated and sustained

26 June 2024